Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

by Scott Larrivee | Aug 21, 2025 | News, Utah

Pictured (L-R): Howard Lewin, Nusano co-founder & Chief Product Development Officer; Glenn Rosenthal, Nusano co-founder & Chief Technology Officer; Chris Lowe, Nusano CEO; John Dahlstrom, EVP, Wasatch Group; and Utah Gov. Spencer Cox.   Utah Governor...

Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals

by Scott Larrivee | Aug 7, 2025 | News

The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board Members WEST VALLEY CITY, Utah – Aug. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the formation of a...

Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes

by Scott Larrivee | Jul 9, 2025 | News

Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass existing commercial methodologies Beam time reservations and isotope supply agreements underway WEST...

Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall

by Scott Larrivee | Jun 26, 2025 | Podcast

In this episode of Talk Radioisotopes, host Scott Larrivee and guest Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and leadership roles...

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

by Scott Larrivee | Jun 26, 2025 | News

The following is a copy of a press release issued by Cellectar Biosciences Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for...